Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
Healthcare news, data and analysis
Via Investors in Healthcare
UK: Epidarex Capital announces first close of Fund IV to build therapeutics and medical device companies in the UK and the US
Epidarex Capital, a UK-based transatlantic life science venture firm, has announced the first close of Epidarex Capital Fund IV, securing more than US$145m in commitments to build therapeutics and medical […]
Epidarex Capital, a UK-based transatlantic life science venture firm, has announced the first close of Epidarex Capital Fund IV, securing more than US$145m in commitments to build therapeutics and medical […]
UK: Epidarex Capital announces first close of Fund IV to build therapeutics and medical device companies in the UK and the US
January 30, 2026
Life Sciences
News
Venture
British Business Bank
Christine Hockley
Germany: Bertelsmann Investments establishes transatlantic Healthcare fund
Bertelsmann Investments (BI), the international venture capital arm of the media, services, and education company Bertelsmann, is consolidating its investment activities in the healthcare sector in a new, independent investment […]
Bertelsmann Investments (BI), the international venture capital arm of the media, services, and education company Bertelsmann, is consolidating its investment activities in the healthcare sector in a new, independent investment […]
Germany: Bertelsmann Investments establishes transatlantic Healthcare fund
January 29, 2026
Healthcare
Life Sciences
News
Venture
Bertelsmann Healthcare Investments (BHI)
Sweden: Essity secures €400m loan from EIB to strengthen innovation capabilities
Hygiene and health company Essity has secured a €400m seven-year loan at favourable terms with the European Investment Bank (EIB). The loan will support the company’s research, development, and innovation initiatives […]
Hygiene and health company Essity has secured a €400m seven-year loan at favourable terms with the European Investment Bank (EIB). The loan will support the company’s research, development, and innovation initiatives […]
Sweden: Essity secures €400m loan from EIB to strengthen innovation capabilities
January 29, 2026
Debt
Life Sciences
News
EIB
Essity
Greece: Dental Holding reinforces footprint in Greece
Romania-based Dental Holding, a dental group in Central and Eastern Europe backed by Abris, is bringing Greece-based Memodent Group (Memodent and Oral Vision IKE), a dental supplies distributor, under its […]
Romania-based Dental Holding, a dental group in Central and Eastern Europe backed by Abris, is bringing Greece-based Memodent Group (Memodent and Oral Vision IKE), a dental supplies distributor, under its […]
Greece: Dental Holding reinforces footprint in Greece
January 28, 2026
Buy Out
Dental
Distribution
Healthcare
M&A
Germany: Kester-backed Evestia Clinical strengthens presence in Europe with acquisition of ICRC-Weyer
Evestia Clinical, an independent UK-based global specialist CRO, has acquired ICRC-Weyer, a Germany-based CRO and scientific consultancy. The acquisition strengthens Evestia Clinical’s presence in Germany and Europe and enhances its […]
Evestia Clinical, an independent UK-based global specialist CRO, has acquired ICRC-Weyer, a Germany-based CRO and scientific consultancy. The acquisition strengthens Evestia Clinical’s presence in Germany and Europe and enhances its […]
Germany: Kester-backed Evestia Clinical strengthens presence in Europe with acquisition of ICRC-Weyer
January 28, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
UK: Hesley Group announces plans for 60 new individual homes by 2030
Hesley Group, a provider of specialist care, support and education, has announced an ambitious growth plan to transform specialist learning disability and autism friendly living and support across the North […]
Hesley Group, a provider of specialist care, support and education, has announced an ambitious growth plan to transform specialist learning disability and autism friendly living and support across the North […]
UK: Hesley Group announces plans for 60 new individual homes by 2030
January 28, 2026
Complex Behavioural Care
Education
News
Real Assets
SEN Schools
Outlook for Healthcare Real Estate in Europe: operators still in recovery mode, capital constrained
Europe’s healthcare real estate sector is entering a period of recalibration. Long-term demographic drivers remain compelling, but financing costs, labour shortages and inflationary pressure on operators have sharpened investor focus […]
Europe’s healthcare real estate sector is entering a period of recalibration. Long-term demographic drivers remain compelling, but financing costs, labour shortages and inflationary pressure on operators have sharpened investor focus […]
Outlook for Healthcare Real Estate in Europe: operators still in recovery mode, capital constrained
January 28, 2026
Analysis
Care Homes
News
Real Assets
Social Care
Switzerland: SK Capital to sell Noramco, Extractas Bioscience, and Purisys to Siegfried
Life sciences PE Firm, SK Capital, is to sell the drug substance business of the Noramco Group and Extractas Bioscience to Six-listed Siegfried Holding, a Switzerland-based CDMO. Following the transaction […]
Life sciences PE Firm, SK Capital, is to sell the drug substance business of the Noramco Group and Extractas Bioscience to Six-listed Siegfried Holding, a Switzerland-based CDMO. Following the transaction […]
Switzerland: SK Capital to sell Noramco, Extractas Bioscience, and Purisys to Siegfried
January 28, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Belgium: Gimv discontinues activities for new Life Sciences investments
Belgium-based private equity firm, Gimv, will not be making any further new investments in its Life Sciences platform. In line with its strategic priorities and growth ambitions, Gimv has decided to focus […]
Belgium-based private equity firm, Gimv, will not be making any further new investments in its Life Sciences platform. In line with its strategic priorities and growth ambitions, Gimv has decided to focus […]
Belgium: Gimv discontinues activities for new Life Sciences investments
January 27, 2026
Life Sciences
News
Venture
Belgium
Gimv
UK: Spire Healthcare confirms discussions on a potential sale with Bridgepoint and Triton
Spire Healthcare, a UK provider of private healthcare, running 38 private hospitals and over 50 clinics, consulting rooms and medical centres, has confirmed it is talking to Bridgepoint and Triton on […]
Spire Healthcare, a UK provider of private healthcare, running 38 private hospitals and over 50 clinics, consulting rooms and medical centres, has confirmed it is talking to Bridgepoint and Triton on […]
UK: Spire Healthcare confirms discussions on a potential sale with Bridgepoint and Triton
January 26, 2026
Healthcare
Hospitals and Clinics
M&A
M&A Deals
News
UK: CMA seeks views on Welltower’s care home acquisitions
The UK Competition and Markets Authority (CMA) is seeking views on four completed acquisitions by Welltower of care homes managed by Barchester, HC-One, Aria Care, and Danforth Care. The request […]
The UK Competition and Markets Authority (CMA) is seeking views on four completed acquisitions by Welltower of care homes managed by Barchester, HC-One, Aria Care, and Danforth Care. The request […]
UK: CMA seeks views on Welltower’s care home acquisitions
January 26, 2026
Care Homes
M&A
M&A Deals
News
Real Assets
US: Bridgefield completes acquisition of Philips’ Emergency Care business and formally launches Emergency Care Holdings
US-based Bridgefield Capital has closed the acquisition, announced in 2025, of the Philips Emergency Care business from Philips and launched Emergency Care Holdings (ECH), a platform developed to acquire and […]
US-based Bridgefield Capital has closed the acquisition, announced in 2025, of the Philips Emergency Care business from Philips and launched Emergency Care Holdings (ECH), a platform developed to acquire and […]
US: Bridgefield completes acquisition of Philips’ Emergency Care business and formally launches Emergency Care Holdings
January 26, 2026
Buy Out
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
Germany: Rudischhauser becomes latest addition to Gilde’s Surgical Instrument Contract Manufacturing Group
Thematic investor Gilde Healthcare has expanded its Surgical Instrument Contract Manufacturing Group (the Group) with the acquisition of Germany-based medtech Rudischhauser Surgical Instruments Manufacturing, a specialist manufacturer of complex surgical […]
Thematic investor Gilde Healthcare has expanded its Surgical Instrument Contract Manufacturing Group (the Group) with the acquisition of Germany-based medtech Rudischhauser Surgical Instruments Manufacturing, a specialist manufacturer of complex surgical […]
Germany: Rudischhauser becomes latest addition to Gilde’s Surgical Instrument Contract Manufacturing Group
January 26, 2026
Buy Out
Life Sciences
M&A
Medtech – Medical Devices and Implants
News
Singapore: Specac acquires Amax Precision
UK-based Specac, an Ampersand Capital Partners portfolio company that designs and manufactures spectroscopy accessories and sample prep solutions, has acquired Amax Precision, a Singapore-headquartered analytical instrument precision contract manufacturer. […]
UK-based Specac, an Ampersand Capital Partners portfolio company that designs and manufactures spectroscopy accessories and sample prep solutions, has acquired Amax Precision, a Singapore-headquartered analytical instrument precision contract manufacturer. […]
Singapore: Specac acquires Amax Precision
January 23, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
France: bioMérieux completes its offering for cell and gene therapies with acquisition of Accellix
France-based bioMérieux, a family-owned global leader in the field of in vitro diagnostics, has acquired the entire share capital of Accellix, increasing its stake from roughly 10% to 100% for a total […]
France-based bioMérieux, a family-owned global leader in the field of in vitro diagnostics, has acquired the entire share capital of Accellix, increasing its stake from roughly 10% to 100% for a total […]
France: bioMérieux completes its offering for cell and gene therapies with acquisition of Accellix
January 23, 2026
Diagnostics
Healthcare
IVD – Tools
Life Sciences
M&A
Italy: Angelini Pharma appoints Sergio Marullo di Condojanni as new CEO
Angelini Pharma, the pharmaceutical division of multinational privately owned industrial group Angelini Industries, has appointed Sergio Marullo di Condojanni as CEO. Already CEO of Angelini Industries, a position he has […]
Angelini Pharma, the pharmaceutical division of multinational privately owned industrial group Angelini Industries, has appointed Sergio Marullo di Condojanni as CEO. Already CEO of Angelini Industries, a position he has […]
Italy: Angelini Pharma appoints Sergio Marullo di Condojanni as new CEO
January 23, 2026
Consumer Healthcare
Healthcare
Manufacturing – Specialty Pharma
Mental Health
News
Switzerland: Oviva raises €200m in one of the biggest Series D rounds in digital health
Switzerland-based Oviva, one of Europe’s leading providers of digital, reimbursed care for weight-related and chronic conditions, has closed a €200m (US$234m) Series D financing round – one of the largest […]
Switzerland-based Oviva, one of Europe’s leading providers of digital, reimbursed care for weight-related and chronic conditions, has closed a €200m (US$234m) Series D financing round – one of the largest […]
Switzerland: Oviva raises €200m in one of the biggest Series D rounds in digital health
January 22, 2026
Digital Health/Healthtech
Healthcare
News
Venture
Christian Scherrer
Germany: Luxempart acquires majority stake in Valeara
Luxembourg-based listed investment company Luxempart has become a majority shareholder of Valeara, a provider of ambulatory mental healthcare services in Germany. It is partnering with Valeara’s existing shareholders led by […]
Luxembourg-based listed investment company Luxempart has become a majority shareholder of Valeara, a provider of ambulatory mental healthcare services in Germany. It is partnering with Valeara’s existing shareholders led by […]
Germany: Luxempart acquires majority stake in Valeara
January 22, 2026
Buy Out
Healthcare
M&A
Mental Health
News
Sweden: EQT entering secondaries market with acquisition of Coller Capital
EQT is acquiring Coller Capital, a UK-headquartered global secondaries firm with nearly US$50bn in total AUM (US$33bn in fee-generating AUM), to form a new Secondaries business segment, alongside EQT’s existing […]
EQT is acquiring Coller Capital, a UK-headquartered global secondaries firm with nearly US$50bn in total AUM (US$33bn in fee-generating AUM), to form a new Secondaries business segment, alongside EQT’s existing […]
Sweden: EQT entering secondaries market with acquisition of Coller Capital
January 22, 2026
Buy Out
Healthcare
Life Sciences
M&A
News
Belgium: Aedifica obtains approval for combination with Cofinimmo
The college of the Belgian Competition Authority (BCA) has approved the combination of Aedifica and Cofinimmo to form a leading healthcare REIT in Europe. The combination of both companies will […]
The college of the Belgian Competition Authority (BCA) has approved the combination of Aedifica and Cofinimmo to form a leading healthcare REIT in Europe. The combination of both companies will […]
Belgium: Aedifica obtains approval for combination with Cofinimmo
January 22, 2026
Care Homes
Complex Behavioural Care
M&A
M&A Deals
News
Spain: Artis BioSolutions acquires CDMO Syngoi Technologies
Buenavista Equity Partners, a private equity group specialising in the Spanish low/mid-market segment, and Spain-based Columbus Venture Partners, are selling their stake in Syngoi Technologies, a Spain-based CDMO specialising in synthetic […]
Buenavista Equity Partners, a private equity group specialising in the Spanish low/mid-market segment, and Spain-based Columbus Venture Partners, are selling their stake in Syngoi Technologies, a Spain-based CDMO specialising in synthetic […]
Spain: Artis BioSolutions acquires CDMO Syngoi Technologies
January 22, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Belgium: Title21 acquires MyCellHub to expand digital capabilities in Life Sciences and advanced therapies
Archimed portfolio company Title21 Health Solutions, a US-based provider of enterprise quality management systems and cell and gene therapy orchestration platforms, has acquired Belgium-based MyCellHub and its manufacturing execution system (MES) platform. […]
Archimed portfolio company Title21 Health Solutions, a US-based provider of enterprise quality management systems and cell and gene therapy orchestration platforms, has acquired Belgium-based MyCellHub and its manufacturing execution system (MES) platform. […]
Belgium: Title21 acquires MyCellHub to expand digital capabilities in Life Sciences and advanced therapies
January 21, 2026
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
Switzerland: Alcon concludes CHF602m share buy-back programme
SIX-listed Alcon, a Switzerland-based global eye care company, has completed a CHF602m (US$750m) share repurchase programme. In aggregate, 9,301,877 registered shares were acquired on the SIX Swiss Exchange, representing 1.9% […]
SIX-listed Alcon, a Switzerland-based global eye care company, has completed a CHF602m (US$750m) share repurchase programme. In aggregate, 9,301,877 registered shares were acquired on the SIX Swiss Exchange, representing 1.9% […]
Switzerland: Alcon concludes CHF602m share buy-back programme
January 21, 2026
Healthcare
News
Ophthalmology
Public Equity
Alcon
UK: GSK agrees acquisition of RAPT Therapeutics in transaction valued at US$2.2bn
London and New York-listed global biopharma GSK is to acquire Nasdaq-listed RAPT Therapeutics, a US-based, clinical-stage biopharma dedicated to developing therapies for patients living with inflammatory and immunologic diseases. GSK […]
London and New York-listed global biopharma GSK is to acquire Nasdaq-listed RAPT Therapeutics, a US-based, clinical-stage biopharma dedicated to developing therapies for patients living with inflammatory and immunologic diseases. GSK […]
UK: GSK agrees acquisition of RAPT Therapeutics in transaction valued at US$2.2bn
January 21, 2026
M&A
Manufacturing – Specialty Pharma
News
Pharma
A&O Shearman
Norway: Summa Equity acquires Norwegian remote care specialist, Dignio
Summa Equity, a Sweden-based investment firm investing to solve global challenges, has acquired Dignio, a Norwegian tech company providing remote healthcare directly in people’s homes in Europe and North America. […]
Summa Equity, a Sweden-based investment firm investing to solve global challenges, has acquired Dignio, a Norwegian tech company providing remote healthcare directly in people’s homes in Europe and North America. […]
Norway: Summa Equity acquires Norwegian remote care specialist, Dignio
January 20, 2026
Buy Out
Homecare
Life Sciences
M&A
Medtech – Healthcare IT
The latest insights from
Compass Carter Osborne
Digital transformation or change fatigue? Navigating tech in health and care
Digital transformation or change fatigue? Navigating tech in health and care
November 24, 2025
Healthcare
Insight
Culture in flux: rebuilding trust in a multi-generational workforce
Culture in flux: rebuilding trust in a multi-generational workforce
October 24, 2025
Healthcare
Insight
